Union Minister of Health & Family Welfare, Dr. Mansukh Mandaviya interacts with doctors and representatives of IMA
“While it is important to be on the alert and follow COVID Appropriate Behaviour including wearing of masks, it is equally important to prevent an infodemic and share only authentic and verified information on COVID19. Union Ministry of Health has been sharing information on various aspects of COVID prevention and management. I urge everyone to […]
FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma
With Lunsumio, people with heavily pre-treated follicular lymphoma may experience remission with a chemotherapy-free, fixed-duration treatment that can be accessed in an outpatient setting Results from the pivotal phase II GO29781 study demonstrated that 80% of patients who received at least two prior therapies achieved durable response rates, with 60% experiencing complete remission Lunsumio is […]
National Health Authority organized ABDM adoption workshop for diagnostic industry representatives
The National Health Authority (NHA) organized a workshop on Ayushman Bharat Digital Mission (ABDM) for the stakeholders of diagnostic industry on 22nd December, 2022 in Lucknow, Uttar Pradesh. The objective of the workshop was to highlight the role of ABDM and the importance of digital health records for the patients, especially the diagnostic reports which […]
NHA aims to promote adoption of Ayushman Bharat Digital Mission (ABDM) by offering incentives of up to Rs. 4 crores to hospitals, labs and digital health solution providers
The National Health Authority (NHA) has announced a Digital Health Incentive Scheme (DHIS) for the stakeholders of the digital health ecosystem. The scheme aims to give a further boost to digital health transactions in the country under the Ayushman Bharat Digital Mission (ABDM). The incentives under this scheme would be provided to hospitals and diagnostic […]
FDA approves Roche’s Actemra for the treatment of COVID-19 in hospitalised adults
Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million people hospitalised with COVID-19 have been treated with Actemra worldwide Actemra is approved for this use in more than 30 countries for the treatment of COVID-19 Basel, 21 December 2022 - Roche (SIX: RO, ROG; […]
WHO prequalifies a second Malaria vaccine, a significant milestone in prevention of the disease
The World Health Organization (WHO) has added the R21/Matrix-M malaria vaccine to the list of prequalified vaccines. In October 2023, WHO recommended its use for the prevention of malaria in children following the advice of the WHO Strategic Advisory Group of Experts (SAGE) on Immunization and the Malaria Policy Advisory Group. The prequalification means larger […]
Ayushman Bharat Digital Mission facilitating Quick OPD registration in hospitals through Scan and Share service
The National Health Authority (NHA) under its flagship scheme Ayushman Bharat Digital Mission (ABDM) offers faster OPD registration service for patients via Scan & Share functionality. The service which was piloted from a single hospital in New Delhi in October 2022, has now been adopted in 200+ health facilities across 18 states in India. Within […]
Dr. Mansukh Mandaviya reviews COVID-19 Situation and Preparedness of public health system for Surveillance, Containment and Management in view of Rising COVID-19 Cases worldwide
Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare today chaired a high-level meeting to review the COVID-19 situation in India and preparedness of public health system for surveillance, containment and management of COVID-19 in view of the recent spike in cases of COVID-19 in some countries along with Dr Bharati Pravin Pawar, Union […]
WHO updates recommendations on HPV vaccination schedule
In a new position paper published last week, WHO has updated its recommendations for the human papillomavirus (HPV) vaccine. Of particular note, the paper states that a single-dose schedule, referred to as an alternative, off-label single–dose schedule can provide a comparable efficacy and durability of protection to a two-dose regimen. The recommendation for alternative single-dose […]
Disease Outbreak News (DON): Circulating vaccine-derived poliovirus type 2 (cVDPV2)-Indonesia
On 12 November 2022, Indonesia’s Ministry of Health notified WHO of a confirmed case of circulating vaccine-derived poliovirus type 2 (cVDPV2) with acute flaccid paralysis (AFP) from Pidie district in Aceh province. Field investigations were immediately launched by local and national public health authorities, with support from partners of the Global Polio Eradication Initiative. On […]
